DAFNA Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $540K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $5.56M | Buy |
|
|||||
|
2022
Q3 | $12.1M | Sell |
|
|||||
|
2022
Q2 | $13.7M | Buy |
|
|||||
|
2022
Q1 | $19.4M | Buy |
|
|||||
|
2021
Q4 | $21.8M | Buy |
|
|||||
|
2021
Q3 | $20.4M | Buy |
|
|||||
|
2021
Q2 | $27.3M | Hold |
|
|||||
|
2021
Q1 | $25.9M | Sell |
|
|||||
|
2020
Q4 | $30.4M | Sell |
|
|||||
|
2020
Q3 | $17.5M | Sell |
|
|||||
|
2020
Q2 | $16.8M | Buy |
|
|||||
|
2020
Q1 | $10.4M | Hold |
|
|||||
|
2019
Q4 | $9.2M | Hold |
|
|||||
|
2019
Q3 | $7.3M | Buy |
|
|||||
|
2019
Q2 | $1.22M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $99K | Sell |
|
|||||
|
2014
Q4 | $297K | Sell |
|
|||||
|
2014
Q3 | $387K | Hold |
|
|||||
|
2014
Q2 | $479K | Buy |
|